Improving cellular therapy operations through pre‐harvest measurement of peripheral CD34 ‐positive cell counts in allogeneic stem cell harvest
Therapeutic Apheresis and Dialysis · 2025-02 · 29 (1) · 131-140
DOI: 10.1111/1744-9987.14202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 27.08.2024. Verfasst von Shuhei Kurosawa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Antigens, CD34. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Previously, our institution measured peripheral blood CD34 cell counts both pre‐ and post‐peripheral blood stem cell harvest (PBSCH), with both samples analyzed simultaneously post‐PBSCH. Since 2021, we have measured pre‐CD34 cell counts during PBSCH, adjusting the processed blood volume based on these results. We retrospectively evaluated how this change impacted cellular therapy.
Methods
Related healthy donors were included and divided into 1‐day and 2‐day harvest cohorts. Donors with CD34 cell counts measured post‐ and during PBSCH were categorized into the previous and current sub‐cohorts, respectively.
Results
Regarding the 1‐day cohort ( n = 212), the current sub‐cohort had a significantly shorter average harvest duration (151 [standard deviation, SD = 45.1] vs. 180 [SD = 27.8] minutes, respectively) and higher average infusion rates (87.6% [SD = 21.1] vs. 78.1% [SD = 25.7], respectively) than the previous sub‐cohort.
Conclusion
Adjusting the processed blood volume based on pre‐PBSCH CD34 cell counts measured during the harvest may reduce donor burden and enhance workflow efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
- Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
ORCID-Profile: Shuhei Kurosawa
Zitieren
APA
Kurosawa, S., Haraguchi, K., Honma, Y., Kawai, F., Ishiwada, M., Iimura, R., Watanabe, R., Ishibashi, S., Sakuma, K., Narishima, K., Nishimura, M., Toya, T., Shimizu, H., Najima, Y., Kobayashi, T., Doki, N., & Okuyama, Y. (2025). Improving cellular therapy operations through pre‐harvest measurement of peripheral CD34 ‐positive cell counts in allogeneic stem cell harvest. Therapeutic Apheresis and Dialysis, 29(1), 131-140. https://doi.org/10.1111/1744-9987.14202
Vancouver
Kurosawa S, Haraguchi K, Honma Y, Kawai F, Ishiwada M, Iimura R, et al. Improving cellular therapy operations through pre‐harvest measurement of peripheral CD34 ‐positive cell counts in allogeneic stem cell harvest. Therapeutic Apheresis and Dialysis. 2025;29(1):131-140. doi:10.1111/1744-9987.14202
BibTeX
@article{Kurosawa2025,
author = {Kurosawa, Shuhei and Haraguchi, Kyoko and Honma, Yunoka and Kawai, Fuyuko and Ishiwada, Moemi and Iimura, Ryoko and Watanabe, Rei and Ishibashi, Sayuri and Sakuma, Kae and Narishima, Kiyomi and Nishimura, Misako and Toya, Takashi and Shimizu, Hiroaki and Najima, Yuho and Kobayashi, Takeshi and Doki, Noriko and Okuyama, Yoshiki},
title = {Improving cellular therapy operations through pre‐harvest measurement of peripheral CD34 ‐positive cell counts in allogeneic stem cell harvest},
journal = {Therapeutic Apheresis and Dialysis},
year = {2025},
volume = {29},
number = {1},
pages = {131--140},
doi = {10.1111/1744-9987.14202}
}
EUVIMED